Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants

There is a paucity of data regarding the phenotype of dilated cardiomyopathy (DCM) gene variants in the general population. We aimed to determine the frequency and penetrance of DCM-associated putative pathogenic gene variants in a general adult population, with a focus on the expression of clinical...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) Vol. 146; no. 2; p. 110
Main Authors: Shah, Ravi A, Asatryan, Babken, Sharaf Dabbagh, Ghaith, Aung, Nay, Khanji, Mohammed Y, Lopes, Luis R, van Duijvenboden, Stefan, Holmes, Anthony, Muser, Daniele, Landstrom, Andrew P, Lee, Aaron Mark, Arora, Pankaj, Semsarian, Christopher, Somers, Virend K, Owens, Anjali T, Munroe, Patricia B, Petersen, Steffen E, Chahal, C Anwar A
Format: Journal Article
Language:English
Published: United States 12.07.2022
Subjects:
Arrhythmias, Cardiac - diagnosis
Arrhythmias, Cardiac - epidemiology
Arrhythmias, Cardiac - genetics
Biological Specimen Banks
Cardiomyopathies - complications
Cardiomyopathy, Dilated - diagnosis
Cardiomyopathy, Dilated - epidemiology
Cardiomyopathy, Dilated - genetics
Humans
Penetrance
United Kingdom - epidemiology
United Kingdom
arrhythmias, cardiac
death, sudden, cardiac
genetics
cardiomyopathies
genetic testing
penetrance
ISSN:1524-4539, 1524-4539
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is a paucity of data regarding the phenotype of dilated cardiomyopathy (DCM) gene variants in the general population. We aimed to determine the frequency and penetrance of DCM-associated putative pathogenic gene variants in a general adult population, with a focus on the expression of clinical and subclinical phenotype, including structural, functional, and arrhythmic disease features. UK Biobank participants who had undergone whole exome sequencing, ECG, and cardiovascular magnetic resonance imaging were selected for study. Three variant-calling strategies (1 primary and 2 secondary) were used to identify participants with putative pathogenic variants in 44 DCM genes. The observed phenotype was graded DCM (clinical or cardiovascular magnetic resonance diagnosis); early DCM features, including arrhythmia or conduction disease, isolated ventricular dilation, and hypokinetic nondilated cardiomyopathy; or phenotype-negative. Among 18 665 individuals included in the study, 1463 (7.8%) possessed ≥1 putative pathogenic variant in 44 DCM genes by the main variant calling strategy. A clinical diagnosis of DCM was present in 0.34% and early DCM features in 5.7% of individuals with putative pathogenic variants. ECG and cardiovascular magnetic resonance analysis revealed evidence of subclinical DCM in an additional 1.6% and early DCM features in an additional 15.9% of individuals with putative pathogenic variants. Arrhythmias or conduction disease (15.2%) were the most common early DCM features, followed by hypokinetic nondilated cardiomyopathy (4%). The combined clinical/subclinical penetrance was ≤30% with all 3 variant filtering strategies. Clinical DCM was slightly more prevalent among participants with putative pathogenic variants in definitive/strong evidence genes as compared with those with variants in moderate/limited evidence genes. In the UK Biobank, ≈1 of 6 of adults with putative pathogenic variants in DCM genes exhibited early DCM features potentially associated with DCM genotype, most commonly manifesting with arrhythmias in the absence of substantial ventricular dilation or dysfunction.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1524-4539
1524-4539
DOI:10.1161/CIRCULATIONAHA.121.058143